Sex differences in response to administration of heparin during non-cardiac arterial procedures.

[1]  J. Connors,et al.  Heparin Resistance - Clinical Perspectives and Management Strategies. , 2021, The New England journal of medicine.

[2]  J. Blankensteijn,et al.  A Standardized Bolus of 5 000 IU of Heparin does not lead to Adequate Heparinization during Non-Cardiac Arterial procedures. , 2020, Annals of vascular surgery.

[3]  P. Rochon,et al.  Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century , 2019, EClinicalMedicine.

[4]  R. de Caterina,et al.  Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. , 2019, International journal of cardiology.

[5]  C. Behrendt,et al.  Population Based Analysis of Gender Disparities in 23,715 Percutaneous Endovascular Revascularisations in the Metropolitan Area of Hamburg. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  Emelie Nissborg,et al.  Anticoagulant Effect of Standard Dose Heparin During Peripheral Endovascular Intervention. , 2019, Annals of vascular surgery.

[7]  J. Blankensteijn,et al.  Individual Differences in Heparin Sensitivity and Their Effect on Heparin Anticoagulation During Arterial Vascular Surgery. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  F. Moll,et al.  The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis , 2016, Scientifica.

[9]  L. Brewster,et al.  Gender and frailty predict poor outcomes in infrainguinal vascular surgery. , 2016, The Journal of surgical research.

[10]  G. Faggian,et al.  European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG registry): Study Protocol for a Prospective Clinical Registry and Proposal of Classification of Postoperative Complications , 2015, Journal of Cardiothoracic Surgery.

[11]  J. Maessen,et al.  An evaluation of factors affecting activated coagulation time. , 2012, Journal of cardiothoracic and vascular anesthesia.

[12]  M. Hunink,et al.  Systematic review and meta‐analysis of sex differences in outcome after intervention for abdominal aortic aneurysm , 2010, The British journal of surgery.

[13]  D. Davenport,et al.  Gender and 30-day outcome in patients undergoing endovascular aneurysm repair (EVAR): an analysis using the ACS NSQIP dataset. , 2009, Journal of vascular surgery.

[14]  P. Olsson,et al.  The elimination from plasma of intravenous heparin. An experimental study on dogs and humans. , 2009, Acta medica Scandinavica.

[15]  E. Antman,et al.  Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction , 2009, Circulation.

[16]  L. Jaques,et al.  Pharmacodynamics and Clinical Effectiveness of Heparin , 2008, Seminars in thrombosis and hemostasis.

[17]  T. Kohlmann,et al.  Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. , 2006, Blood.

[18]  P. Devine,et al.  The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement. , 2005, The journal of extra-corporeal technology.

[19]  Tamar Frankel.  [The theory and the practice...]. , 2001, Tijdschrift voor diergeneeskunde.

[20]  F. Follath,et al.  Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.

[21]  S. Knowles,et al.  Gender Differences in Adverse Drug Reactions , 1998, Journal of clinical pharmacology.

[22]  Wilson,et al.  The Effect of Body Weight and Body Surface Area Correction on the Distribution of the ACT Response to Bolus Doses of Heparin for PTCA. , 1998, The Journal of invasive cardiology.

[23]  G. Raskob,et al.  Different effects of heparin in males and females. , 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

[24]  R. Kandrotas,et al.  Heparin Pharmacokinetics and Pharmacodynamics , 1992, Clinical pharmacokinetics.

[25]  C. D. de Swart,et al.  Kinetics of intravenously administered heparin in normal humans. , 1982, Blood.

[26]  T. Bjornsson,et al.  Heparin kinetics determined by three assay methods , 1982, Clinical pharmacology and therapeutics.

[27]  W. Coon.  Heparin: A drug of varying composition and effectiveness , 1978, Clinical pharmacology and therapeutics.

[28]  R. Rosenberg.  Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.

[29]  F. Moll,et al.  Prophylactic intraoperative antithrombotics in open infrainguinal arterial bypass surgery: a systematic review. , 2015, The Journal of cardiovascular surgery.

[30]  G. Anderson.  Gender differences in pharmacological response. , 2008, International review of neurobiology.

[31]  S. Seremetis.  Sex-related differences in hemostasis and thrombosis. , 2001, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[32]  B. Boneu,et al.  Pharmacokinetics of heparin and low molecular weight heparin. , 1990, Bailliere's clinical haematology.